A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene

Vaccine. 1993 Sep;11(12):1253-8. doi: 10.1016/0264-410x(93)90051-x.

Abstract

Fragments of the alpha-toxin of Clostridium perfringens have been produced using genetic manipulation techniques. Antibody which cross-reacted with the alpha-toxin was induced after immunization with fragments representing the N- (Cpa1-249) and C-terminal (Cpa247-370) domains of the toxin. Smaller fragments of the alpha-toxin did not induce cross-reacting antibody. Anti-Cpa1-249 serum neutralized phospholipase C activity but not haemolytic activity of the toxin. Anti-Cpa247-370 serum neutralized both the phospholipase C and haemolytic activities. Only immunization with Cpa247-370 induced protection against the lethal effects of the toxin. Immunization with Cpa247-370 also provided protection in a mouse model against at least 10 LD100 doses of C. perfringens type A. This result confirms the essential role of this toxin in the pathogenesis of gas gangrene.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antibodies / immunology
  • Antibody Formation
  • Bacterial Toxins / antagonists & inhibitors
  • Bacterial Toxins / toxicity*
  • Bacterial Vaccines / therapeutic use*
  • Calcium-Binding Proteins*
  • Clostridium perfringens / immunology*
  • Disease Models, Animal
  • Female
  • Gas Gangrene / prevention & control*
  • Genetic Engineering / methods
  • Mice
  • Mice, Inbred BALB C
  • Molecular Sequence Data
  • Peptide Fragments / antagonists & inhibitors
  • Peptide Fragments / immunology
  • Peptide Fragments / toxicity
  • Type C Phospholipases*
  • Vaccines, Synthetic / biosynthesis
  • Vaccines, Synthetic / therapeutic use

Substances

  • Antibodies
  • Bacterial Toxins
  • Bacterial Vaccines
  • Calcium-Binding Proteins
  • Peptide Fragments
  • Vaccines, Synthetic
  • Type C Phospholipases
  • alpha toxin, Clostridium perfringens